Abstract
A common feature of congenital heart disease is the presence of right ventricular outflow tract (RVOT) obstruction that can range from mild to severe and can lead to atresia of the pulmonary valve, in extreme conditions. RVOT abnormalities can frequently be corrected surgically or via interventional means. However, most of these patients will ultimately develop pulmonary valve insufficiency and eventual right ventricular dilation, which will require a pulmonary valve replacement at some point in their life to mitigate the detrimental effects of pulmonary valve regurgitation (PVR) on the right ventricle (RV). The evolution from the studies done by Philip Bonhoeffer to implant a pulmonary valve via transcatheter means, have provided a bedrock for transcatheter pulmonary valve replacement (TPVR). Yet, several areas of unmet need for a demographic of patients still exist. Here, we discuss the clinical unmet needs in children under 20 Kg and expand the use of hybrid and other TPVR approaches along with the current indications and contraindications for pulmonary valve replacement. The constraints and limitations from commercially available pulmonary valves will be discussed from a clinical standpoint. Finally, we explore the use of hybrid and periventricular delivery of transcatheter pulmonary valves in younger patients.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10439-023-03328-5/MediaObjects/10439_2023_3328_Fig1_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10439-023-03328-5/MediaObjects/10439_2023_3328_Fig2_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10439-023-03328-5/MediaObjects/10439_2023_3328_Fig3_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10439-023-03328-5/MediaObjects/10439_2023_3328_Fig4_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10439-023-03328-5/MediaObjects/10439_2023_3328_Fig5_HTML.jpg)
Similar content being viewed by others
References
Abdelghani, M., M. Nassif, N. A. Blom, M. S. Van Mourik, B. Straver, D. R. Koolbergen, J. Kluin, J. G. Tijssen, B. J. M. Mulder, B. J. Bouma, and R. J. de Winter. Infective endocarditis after melody valve implantation in the pulmonary position: a systematic review. J. Am. Heart Assoc.7:e008163, 2018.
Alkashkari, W., S. Albugami, M. Abbadi, A. Niyazi, A. Alsubei, and Z. M. Hijazi. Transcatheter pulmonary valve replacement in pediatric patients. Expert Rev. Med. Devices. 17:541–554, 2020.
Armstrong, A. K., F. Berger, T. K. Jones, J. W. Moore, L. N. Benson, J. P. Cheatham, D. R. Turner, J. F. Rhodes, J. A. Vincent, T. Zellers, T.-H. Lung, A. Eicken, and D. B. McElhinney. Association between patient age at implant and outcomes after transcatheter pulmonary valve replacement in the multicenter Melody valve trials. Catheter. Cardiovasc. Interv. 94(4):607–617, 2019.
Bartra, S. Transcatheter pulmonary valve replacement in patients with congenital heart disease. Critical Care Nurse. 38:30–36, 2018.
Benson, L. N., M. J. Gillespie, L. Bergersen, S. L. Cheatham, K. N. Hor, E. M. Horlick, S. Weng, B. T. McHenry, M. D. Osten, A. J. Powell, and J. P. Cheatham. Three-year outcomes from the harmony native outflow tract early feasibility study. Circulation. 13:e008320, 2020.
Berman, D. P., D. B. McElhinney, J. A. Vincent, W. E. Hellenbrand, and E. M. Zahn. Feasibility and short-term outcomes of percutaneous transcatheter pulmonary valve replacement in small (<30 kg) children with dysfunctional right ventricular outflow tract conduits. Circulation. 7:142–148, 2014.
Best, K. E., and J. Rankin. Long-term survival of individuals born with congenital heart disease: a systematic review and meta-analysis. J. Am. Heart Assoc.5:e002846, 2016.
Boe, B. A., S. L. Cheatham, A. K. Armstrong, D. P. Berman, J. L. Chisolm, and J. P. Cheatham. Leaflet morphology classification of the Melody Transcatheter Pulmonary Valve. Congenital Heart Dis. 14:297–304, 2019.
Bonhoeffer, P., Y. Boudjemline, Z. Saliba, J. Merckx, Y. Aggoun, D. Bonnet, P. Acar, J. Le Bidois, D. Sidi, and J. Kachaner. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. The Lancet. 356:1403–1405, 2000.
Cabalka, A. K., J. D. Asnes, D. T. Balzer, J. P. Cheatham, M. J. Gillespie, T. K. Jones, H. Justino, D. W. Kim, T.-H. Lung, D. R. Turner, and D. B. McElhinney. Transcatheter pulmonary valve replacement using the melody valve for treatment of dysfunctional surgical bioprostheses: a multicenter study. J. Thorac. Cardiovasc. Surg. 155:1712-1724.e1711, 2018.
Cabalka, A. K., W. E. Hellenbrand, A. Eicken, J. Kreutzer, R. G. Gray, L. Bergersen, F. Berger, A. K. Armstrong, J. P. Cheatham, E. M. Zahn, and D. B. McElhinney. Relationships among conduit type, pre-stenting, and outcomes in patients undergoing transcatheter pulmonary valve replacement in the prospective North American and European Melody Valve Trials. Cardiovasc. Interv. 10:1746–1759, 2017.
Cho, Y. K., and J. S. Ma. Right ventricular failure in congenital heart disease. Korean J Pediatrics. 56:101–106, 2013.
Class 1 Device Recall Harmony Delivery Catheter System.
Dohlen, G., R. R. Chaturvedi, L. N. Benson, A. Ozawa, G. S. Van Arsdell, D. S. Fruitman, and K. J. Lee. Stenting of the right ventricular outflow tract in the symptomatic infant with tetralogy of Fallot. Heart. 95:142–147, 2009.
Dolk, H., M. Loane, and E. Garne. Congenital heart defects in Europe. Circulation. 123:841–849, 2011.
Esmaeili A., M. Khalil, K. Behnke-Hall, M. B. Gonzalez Y Gonzalez, G. Kerst, S. Fichtlscherer, H. Akintuerk, and D. Schranz. Percutaneous pulmonary valve implantation (PPVI) in non-obstructive right ventricular outflow tract: limitations and mid-term outcomes. Translational Pediatrics 8:107–113, 2019.
Gatzoulis, M. A., S. Balaji, S. A. Webber, S. C. Siu, J. S. Hokanson, C. Poile, M. Rosenthal, M. Nakazawa, J. H. Moller, P. C. Gillette, G. D. Webb, and A. N. Redington. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. The Lancet. 356:975–981, 2000.
Gilboa, S. M., O. J. Devine, J. E. Kucik, M. E. Oster, T. Riehle-Colarusso, W. N. Nembhard, P. Xu, A. Correa, K. Jenkins, and A. J. Marelli. Congenital heart defects in the United States. Circulation. 134:101–109, 2016.
Güzeltaş, A. Implantation of the Edwards SAPIEN XT and SAPIEN 3 valves for pulmonary position in enlarged native right ventricular outflow tract. Anatolian J. Cardiol. 25:96, 2020.
Haas, N. A., R. G. Carere, O. Kretschmar, E. Horlick, J. Rodés-Cabau, D. de Wolf, M. Gewillig, M. Mullen, A. Lehner, C. Deutsch, P. Bramlage, and P. Ewert. Early outcomes of percutaneous pulmonary valve implantation using the Edwards SAPIEN XT transcatheter heart valve system. Int. J. Cardiol. 250:86–91, 2018.
Haddad, F., R. Doyle, D. J. Murphy, and S. A. Hunt. Right ventricular function in cardiovascular disease, Part II. Circulation. 117:1717–1731, 2008.
Hascoet, S., R. Dalla Pozza, J. Bentham, R. G. Carere, M. Kanaan, P. Ewert, E. K. Biernacka, O. Kretschmar, C. Deutsch, F. Lecerf, A. Lehner, M. Kantzis, J. Kurucova, M. Thoenes, P. Bramlage, and N. A. Haas. Early outcomes of percutaneous pulmonary valve implantation using the Edwards SAPIEN 3 transcatheter heart valve system. EuroIntervention. 14:1378–1385, 2019.
Hoffman, J. I. E., and S. Kaplan. The incidence of congenital heart disease. J. Am. Coll. Cardiol. 39:1890–1900, 2002.
Jones, T. K., D. B. McElhinney, J. A. Vincent, W. E. Hellenbrand, J. P. Cheatham, D. P. Berman, E. M. Zahn, D. M. Khan, J. F. Rhodes, S. Weng, and L. J. Bergersen. Long-term outcomes after melody transcatheter pulmonary valve replacement in the US investigational device exemption trial. Circulation. 15:e010852, 2022.
Kenny, D., J. F. Rhodes, G. A. Fleming, S. Kar, E. M. Zahn, J. Vincent, G. S. Shirali, J. Gorelick, M. A. Fogel, J. T. Fahey, D. W. Kim, V. C. Babaliaros, A. K. Armstrong, and Z. M. Hijazi. 3-year outcomes of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position from the compassion multicenter clinical trial. Cardiovasc. Interv. 11:1920–1929, 2018.
Khambadkone, S., L. Coats, A. Taylor, Y. Boudjemline, G. Derrick, V. Tsang, J. Cooper, V. Muthurangu, S. R. Hegde, R. S. Razavi, D. Pellerin, J. Deanfield, and P. Bonhoeffer. Percutaneous pulmonary valve implantation in humans. Circulation. 112:1189–1197, 2005.
Kim, A. Y., J. W. Jung, S. Y. Jung, J. I. Shin, L. Y. Eun, N. K. Kim, and J. Y. Choi. Early outcomes of percutaneous pulmonary valve implantation with pulsta and melody valves: the first report from korea. J. Clin. Med. 9:1–14, 2020.
Labs D. Pediatric Heart Valve | Draper. 2022.
Le Ruz, R., J. Plessis, A. Houeijeh, A. E. Baruteau, L. Le Gloan, K. WarinFresse, C. Karsenty, J. Petit, F. Godart, S. Hascoët, and P. Guérin. Edwards SAPIEN XT transcatheter pulmonary valve implantation: 5-year follow-up in a French Registry. Catheter. Cardiovasc. Interv. 98:990–999, 2021.
Lindsey, C. W., W. J. Parks, B. E. Kogon, D. Sallee, and W. T. Mahle. Pulmonary valve replacement after tetralogy of Fallot repair in preadolescent patients. Ann. Thorac. Surg. 89:147–151, 2010.
Liu, Y., S. Chen, L. Zühlke, G. C. Black, M.-K. Choy, N. Li, and B. D. Keavney. Global birth prevalence of congenital heart defects 1970–2017: updated systematic review and meta-analysis of 260 studies. Int. J. Epidemiol. 48:455–463, 2019.
Loverix, L., T. Juvonen, and F. Biancari. Prosthetic endocarditis after transcatheter aortic valve implantation: pooled individual patient outcome. Int. J. Cardiol. 178:67–68, 2015.
Martin, M. H., J. Meadows, D. B. McElhinney, B. H. Goldstein, L. Bergersen, A. M. Qureshi, S. Shahanavaz, J. Aboulhosn, D. Berman, L. Peng, M. Gillespie, A. Armstrong, C. Weng, L. L. Minich, and R. G. Gray. Safety and feasibility of melody transcatheter pulmonary valve replacement in the native right ventricular outflow tract. Cardiovasc. Interv. 11:1642–1650, 2018.
Martin, M. H., S. Shahanavaz, L. F. Peng, J. D. Asnes, M. Riley, W. E. Hellenbrand, D. T. Balzer, R. G. Gray, and D. B. McElhinney. Percutaneous transcatheter pulmonary valve replacement in children weighing less than 20 kg. Catheter. Cardiovasc. Interv. 91:485–494, 2018.
McElhinney, D. B., J. P. Cheatham, T. K. Jones, J. E. Lock, J. A. Vincent, E. M. Zahn, and W. E. Hellenbrand. Stent fracture, valve dysfunction, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation patient-related and procedural risk factors in the US melody valve trial. Circ. Cardiovasc. Interv. 4:602–614, 2011.
McElhinney, D. B., and J. T. Hennesen. The Melody® valve and Ensemble® delivery system for transcatheter pulmonary valve replacement. Ann. N. Y. Acad. Sci. 1291:77–85, 2013.
Mery, C. M., F. A. Guzmán-Pruneda, L. E. De León, W. Zhang, M. D. Terwelp, C. E. Bocchini, I. Adachi, J. S. Heinle, E. D. McKenzie, and C. D. Fraser Jr. Risk factors for development of endocarditis and reintervention in patients undergoing right ventricle to pulmonary artery valved conduit placement. J. Thorac. Cardiovasc. Surg. 151:432–439, 2016.
Mitropoulos, F. M., M. A. Kanakis, C. Ntellos, C. Loukas, P. Davlouros, T. Kousi, and A. C. Chatzis. Pulmonary valve replacement in patients with corrected tetralogy of Fallot. J. Cardiovasc. Thorac. Res. 9:71–77, 2017.
Morray, B. H., and D. B. McElhinney. Updates on transcatheter pulmonary valve replacement. Prog. Pediatric Cardiol. 61:101345–101345, 2021.
Nordmeyer, J., P. Ewert, M. Gewillig, M. AlJufan, M. Carminati, O. Kretschmar, A. Uebing, I. Dähnert, R. Röhle, H. Schneider, M. Witsenburg, L. Benson, R. Gitter, R. Bökenkamp, V. Mahadevan, and F. Berger. Acute and midterm outcomes of the post-approval MELODY registry: a multicentre registry of transcatheter pulmonary valve implantation. Eur. Heart J. 40:2255–2264, 2019.
O’Byrne, M. L., A. C. Glatz, L. Mercer-Rosa, M. J. Gillespie, Y. Dori, E. Goldmuntz, S. Kawut, and J. J. Rome. Trends in pulmonary valve replacement in children and adults with tetralogy of Fallot. Am. J. Cardiol. 115:118–124, 2015.
Oster, M. E., K. A. Lee, M. A. Honein, T. Riehle-Colarusso, M. Shin, and A. Correa. Temporal trends in survival among infants with critical congenital heart defects. Pediatrics. 131:e1502–e1508, 2013.
Patel, N. D., D. S. Levi, J. P. Cheatham, S. A. Qureshi, S. Shahanavaz, and E. M. Zahn. Transcatheter pulmonary valve replacement: a review of current valve technologies. J. Soc. Cardiovasc. Angiography Interv. 1:100452–100452, 2022.
Premarket Approval (PMA)- Harmony™ Delivery Catheter System. 2023.
Premarket Approval (PMA)- Harmony™ Transcatheter Pulmonary Valve, Harmony™ Delivery Catheter System. 2023.
Puls, M., H. Eiffert, M. Hünlich, F. Schöndube, G. Hasenfuß, R. Seipelt, and W. Schillinger. Prosthetic valve endocarditis after transcatheter aortic valve implantation: the incidence in a single-centre cohort and reflections on clinical, echocardiographic and prognostic features. EuroIntervention. 8:1407–1418, 2013.
Reller, M. D., M. J. Strickland, T. Riehle-Colarusso, W. T. Mahle, and A. Correa. Prevalence of congenital heart defects in metropolitan Atlanta, 1998–2005. J. Pediatrics. 153:807–813, 2008.
Rheude, T., J. Blumenstein, H. Möllmann, and O. Husser. Spotlight on the SAPIEN 3 transcatheter heart valve. Med. Devices. 11:353–360, 2018.
Rockefeller, T., S. Shahanavaz, A. Zajarias, and D. Balzer. Pediatric And congenital heart disease case report transcatheter implantation of SAPIEN 3 valve in native right ventricular outflow tract for severe pulmonary regurgitation following tetralogy of Fallot repair. Catheter. Cardiovasc. Interv. 88(1):E28–E33, 2016.
Ruiz, C. E., and T. K. R. Pasala. Are we ready for transcatheter pulmonary valve replacement in native right ventricular outflow tract? Cardiovasc. Interv. 11:1651–1653, 2018.
Sandoval, J. P., R. R. Chaturvedi, L. Benson, G. Morgan, G. Van Arsdell, O. Honjo, C. Caldarone, and K.-J. Lee. Right ventricular outflow tract stenting in tetralogy of Fallot infants with risk factors for early primary repair. Circulation.9:e003979, 2016.
Shahanavaz, S., E. M. Zahn, D. S. Levi, J. A. Aboulhousn, S. Hascoet, A. M. Qureshi, D. Porras, G. J. Morgan, H. Bauser Heaton, M. H. Martin, B. Keeshan, J. D. Asnes, D. Kenny, J. M. Ringewald, J. E. Zablah, M. Ivy, B. H. Morray, A. J. Torres, D. P. Berman, M. J. Gillespie, K. Chaszczewski, J. D. Zampi, K. P. Walsh, P. Julien, B. H. Goldstein, S. K. Sathanandam, C. Karsenty, D. T. Balzer, and D. B. McElhinney. Transcatheter pulmonary valve replacement with the sapien prosthesis. J. Am. Coll. Cardiol. 76:2847–2858, 2020.
Shibbani, K., J. Aboulhosn, D. Levi, B. Mohammad Nijres, B. Blais, M. Karimi, G. Van Arsdell, and O. Aldoss. Hybrid approach for harmony transcatheter pulmonary valve replacement. Catheter. Cardiovasc. Interv. 101:135–139, 2023.
Sinha, S., J. Aboulhosn, J. Asnes, M. Bocks, E. Zahn, B. H. Goldstein, J. Zampi, W. Hellenbrand, M. Salem, and D. Levi. Initial results from the off-label use of the SAPIEN S3 valve for percutaneous transcatheter pulmonary valve replacement: a multi-institutional experience. Catheter. Cardiovasc. Interv. 93:455–463, 2019.
Tanase, D., S. Georgiev, A. Eicken, and P. Ewert. The Sapien valve provides enough grip to be implanted in pulmonary position without a pre-stent. Cardiovasc. Diagn. Ther. 9:S264–S268, 2019.
Tezza, M., M. Witsenburg, K. Nieman, P. C. van de Woestijne, and R. P. J. Budde. Cardiac CT to assess the risk of coronary compression in patients evaluated for percutaneous pulmonary valve implantation. Eur. J. Radiol. 110:88–96, 2019.
Toggweilera, S., and J. G. Webb. Challenges in transcatheter aortic valve implantation. Swiss Med. Weekly. 142:W13735, 2012.
Tweddell, J. S., P. Simpson, S.-H. Li, J. Dunham-Ingle, P. J. Bartz, M. G. Earing, and A. N. Pelech. Timing and technique of pulmonary valve replacement in the patient with tetralogy of Fallot. Semin. Thorac. Cardiovasc. Surg. 15:27–33, 2012.
Voelkel, N. F., R. A. Quaife, L. A. Leinwand, R. J. Barst, M. D. McGoon, D. R. Meldrum, J. Dupuis, C. S. Long, L. J. Rubin, F. W. Smart, Y. J. Suzuki, M. Gladwin, E. M. Denholm, and D. B. Gail. Right ventricular function and failure. Circulation. 114:1883–1891, 2006.
Warner, K. G., P. K. H. O’Brien, J. Rhodes, A. Kaur, D. A. Robinson, and D. D. Payne. Expanding the indications for pulmonary valve replacement after repair of tetralogy of Fallot. Ann. Thorac. Surg. 76:1066–1071, 2003.
Funding
This work is funded by a National Science Foundation Grant 2109959 and NIH Grants 1R21 HD105889-01, 1 R01 HL162687-01A1, 1 R01 HL157631-01A1, and 1R01 HL153724-01A1.
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor Stefan M. Duma oversaw the review of this article.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Agwu, N., Recto, M.R. & Kheradvar, A. Unmet Clinical Needs for Transcatheter Pulmonary Valves. Ann Biomed Eng 51, 2384–2392 (2023). https://doi.org/10.1007/s10439-023-03328-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10439-023-03328-5